Article Outline
Back to Article Outline
Instructions for category 1 continuing medical education credit
The American Academy of Allergy, Asthma and Immunology is accredited as a provider of Continuing Medical Education (CME) by the Accreditation Council for Continuing Medical Education.
Test ID no.: mai0026
Contact hours: 1.0
Expiration date: December 31, 2004
Category 1 credit can be earned by reading the text material and taking this CME examination online. For complete instructions, visit the Journal's Web site at www.mosby.com/jaci.
Back to Article Outline
Learning objectives: “eosinophilic gastrointestinal disorders”
1.To achieve an understanding of the proper workup and treatment of eosinophilic gastrointestinal disorders.
2.To achieve an understanding of the latest information about the pathogenesis of eosinophilic gastrointestinal disorders.
Back to Article Outline
CME items
Question 1.The diagnosis of eosinophilic gastrointestinal disorders is best made by which of the following?
A.careful review of history and symptoms
B.review of laboratory findings
C.DNA analysis for the FIP1L1-PDGFRA fusion gene
D.histologic analysis of endoscopic biopsy
Question 2.The pathogenesis of eosinophilic gastrointestinal disorders primarily involves which of the following?
A.TH2 associated allergic response
B.eotaxin-2–dependent eosinophilia
C.IL-3–activated mast cells
D.endotoxin-mediated Toll-like receptor signaling
Question 3.The best treatment of eosinophilic gastrointestinal disorders involves which of the following?
A.neutralization of gastric acidity (anti-GERD therapy)
B.systemic glucocorticoids
C.a combination of allergen avoidance and topical glucocorticoid therapy
D.myelosuppressive drug therapy
Question 4.Which of the following clinical or laboratory findings in a patient with an eosinophilic gastrointestinal disorder should prompt a workup for the idiopathic hypereosinophilic syndrome?
A.refractory gastrointestinal symptoms
B.microcytic anemia
C.severe asthma
D.elevated blood eosinophilia
PII: S0091-6749(03)02532-6
doi:10.1016/j.jaci.2003.10.048
© 2004 American Academy of Allergy, Asthma and Immunology. Published by Elsevier Inc. All rights reserved.
